Cencora (COR)

• Market cap: $53.1B
• 1 day: 0.95%
• 5 days: 2.19%
• 1 month: 10.02%
• 3 months: 20.73%
• 6 months: 21.81%
• Year to date: 21.91%
• 1 year: 11.99%
• 5 years: 53.14%
• 10 years: 53.14%
• Sector: Healthcare
• Industry: Drugs, Proprietaries & Druggists Sundries

About: Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Employees: 46,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

87% more first-time investments, than exits

New positions opened: 168 | Existing positions closed: 90

30% more call options, than puts

Call options by funds: $1.2B | Put options by funds: $924M

22% more repeat investments, than reductions

Existing positions increased: 472 | Existing positions reduced: 386

5% more funds holding

Funds holding: 1,146 [Q3] → 1,199 (+53) [Q4]

0.48% less ownership

Funds ownership: 100.62% [Q3] → 100.13% (-0.48%) [Q4]

3% less capital invested

Capital invested by funds: $44.6B [Q3] → $43.5B (-$1.12B) [Q4]

20% less funds holding in top 10

Funds holding in top 10: 15 [Q3] → 12 (-3) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $251 8% downside
• Avg. target: $277 1% upside
• High target: $301 10% upside

4 analyst ratings

• positive: 2 50%
• neutral: 2 50%
• negative: 0 0%

Wells Fargo Stephen Baxter 33% 1-year accuracy 13 / 39 met price target	0% upside $274	Equal-Weight Maintained	14 Mar 2025
Evercore ISI Group John Belton 75% 1-year accuracy 3 / 4 met price target	2% upside $280	Outperform Maintained	6 Feb 2025
Wells Fargo Eric Luebchow 33% 1-year accuracy 15 / 45 met price target	8% downside $251	Equal-Weight Maintained	29 Jan 2025
JP Morgan Lisa Gill 70% 1-year accuracy 16 / 23 met price target	10% upside $301	Overweight Maintained	24 Jan 2025